Mesenchymal stem cells and kidney repair

Nephrology Dialysis Transplantation

Volumn 28, Issue 4, 2013, Pages 788-793

  Morigi, Marina ^a   Benigni, Ariela ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

acute renal failure; kidney; mesenchymal; stem cell

Indexed keywords

CISPLATIN; CREATININE; CYTOKINE; FIBROBLAST GROWTH FACTOR 2; GAMMA INTERFERON; GROWTH FACTOR; HERMES ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 1BETA; MELATONIN; MESSENGER RNA; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ACUTE KIDNEY FAILURE; AGE DISTRIBUTION; AMNION FLUID; CELL COMMUNICATION; CELL HOMING; CELL MOTILITY; CELL PROTECTION; CELL SURVIVAL; CHRONIC KIDNEY DISEASE; CONGESTIVE HEART FAILURE; CORD BLOOD STEM CELL TRANSPLANTATION; CORNEA DISEASE; CREATININE BLOOD LEVEL; CYTOLOGY; DIABETES MELLITUS; DNA MODIFICATION; ENGRAFTMENT; EXOSOME; HEART; HEART INJURY; HEART LEFT VENTRICLE FAILURE; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IN VITRO STUDY; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY PARENCHYMA; MEDICAL RESEARCH; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NEPHROTOXICITY; NONHUMAN; OPEN HEART SURGERY; PARACRINE SIGNALING; PHASE 1 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; REGENERATION; RENAL PROTECTION; REPERFUSION INJURY; REVIEW; RNA TRANSPORT; SKIN DISEASE; SOLID TUMOR; TISSUE REGENERATION; TREATMENT RESPONSE; TROPISM; UPREGULATION;

ACUTE KIDNEY INJURY; ANIMALS; HUMANS; MESENCHYMAL STROMAL CELLS;

EID: 84875971568     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs556     Document Type: Review

References (53)

1. Daley GQ. The promise and perils of stem cell therapeutics. Cell Stem Cell 2012; 10: 740-749
2. Gerczuk PZ, Kloner RA. An update on cardioprotection: a review of the latest adjunctive therapies to limit myocardial infarction size in clinical trials. J Am Coll Cardiol 2012; 59: 969-978
3. Orlic D, Kajstura J, Chimenti S et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001; 410: 701-705 (Pubitemid 32290358)
4. Murry CE, Soonpaa MH, Reinecke H et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004; 428: 664-668 (Pubitemid 38524810)
5. Balsam LB, Wagers AJ, Christensen JL et al. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004; 428: 668-673 (Pubitemid 38524811)
6. Rosenzweig A. Cardiac cell therapy-mixed results from mixed cells. N Engl J Med 2006; 355: 1274-1277 (Pubitemid 44427452)
7. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008; 8: 726-736
8. Le Blanc K, Mougiakakos D. Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol 2012; 12: 383-396
9. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997; 276: 71-74 (Pubitemid 27161245)
10. Edwards RG, Hollands P. Will stem cells in cord blood, amniotic fluid, bone marrow and peripheral blood soon be unnecessary in transplantation? Reprod Biomed Online 2007; 14: 396-401 (Pubitemid 46463640)
11. Flynn A, Barry F, O'Brien T. UC blood-derived mesenchymal stromal cells: an overview. Cytotherapy 2007; 9: 717-726 (Pubitemid 350226750)
12. Crisan M, Yap S, Casteilla L et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008; 3: 301-313
13. Bruno S, Bussolati B, Grange C et al. Isolation and characterization of resident mesenchymal stem cells in human glomeruli. Stem Cells Dev 2009; 18: 867-880
14. Casiraghi F, Noris M, Remuzzi G. Immunomodulatory effects of mesenchymal stromal cells in solid organ transplantation. Curr Opin Organ Transplant 2010; 15: 731-737
15. Poulsom R, Forbes SJ, Hodivala-Dilke K et al. Bone marrow contributes to renal parenchymal turnover and regeneration. J Pathol 2001; 195: 229-235 (Pubitemid 32899033)
16. Ito T, Suzuki A, Imai E et al. Bone marrow is a reservoir of repopulating mesangial cells during glomerular remodeling. J Am Soc Nephrol 2001; 12: 2625-2635 (Pubitemid 33115409)
17. Li B, Morioka T, Uchiyama M et al. Bone marrow cell infusion ameliorates progressive glomerulosclerosis in an experimental rat model. Kidney Int 2006; 69: 323-330 (Pubitemid 43323083)
18. Wise AF, Ricardo SD. Mesenchymal stem cells in kidney inflammation and repair. Nephrology 2012; 17: 1-10
19. Morigi M, Imberti B, Zoja C et al. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol 2004; 15: 1794-1804 (Pubitemid 38822058)
20. Imberti B, Morigi M, Tomasoni S et al. Insulin-like growth factor-1 sustains stem cell mediated renal repair. J Am Soc Nephrol 2007; 18: 2921-2928 (Pubitemid 350058399)
21. Morigi M, Introna M, Imberti B et al. Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice. Stem Cells 2008; 26: 2075-2082
22. Pappa KI, Anagnou NP. Novel sources of fetal stem cells: where do they fit on the developmental continuum? Regen Med 2009; 4: 423-433
23. Panepucci RA, Siufi JL, Silva WA, Jr et al. Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells. Stem Cells 2004; 22: 1263-1278 (Pubitemid 39646504)
24. Morigi M, Rota C, Montemurro T et al. Life-sparing effect of human cord blood-mesenchymal stem cells in experimental acute kidney injury. Stem Cells 2010; 28: 513-522
25. De Coppi P, Bartsch G, Jr, Siddiqui MM et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 2007; 25: 100-106 (Pubitemid 46087908)
26. Rota C, Imberti B, Pozzobon M et al. Human amniotic fluid stem cell preconditioning improves their regenerative potential. Stem Cells Dev 2012; 21: 1911-1923
27. Togel F, Hu Z, Weiss K et al. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol 2005; 289: F31-F42 (Pubitemid 40863570)
28. Togel F, Weiss K, Yang Y et al. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol 2007; 292: F1626-F1635 (Pubitemid 46701891)
29. Bi B, Schmitt R, Israilova M et al. Stromal cells protect against acute tubular injury via an endocrine effect. J Am Soc Nephrol 2007; 18: 2486-2496 (Pubitemid 47378865)
30. Togel F, Cohen A, Zhang P et al. Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury. Stem Cells Dev 2009; 18: 475-485
31. Ratajczak J, Wysoczynski M, Hayek F et al. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 2006; 20: 1487-1495 (Pubitemid 44264090)
32. Fevrier B, Raposo G. Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr Opin Cell Biol 2004; 16: 415-421 (Pubitemid 38903148)
33. Bruno S, Grange C, Deregibus MC et al. Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol 2009; 20: 1053-1067
34. Tomasoni S, Longaretti L, Rota C et al. Transfer of growth factor receptor mRNA via exosomes unravels the regenerative effect of mesenchymal stem cells. Stem Cells Dev 2012; [Epub ahead of print]
35. Biancone L, Bruno S, Deregibus MC et al. Therapeutic potential of mesenchymal stem cell-derived microvesicles. Nephrol Dial Transplant 2012; 27: 3037-3042
36. Herrera MB, Bussolati B, Bruno S et al. Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int J Mol Med 2004; 14: 1035-1041
37. Semedo P, Palasio CG, Oliveira CD et al. Early modulation of inflammation by mesenchymal stem cell after acute kidney injury. Int Immunopharmacol 2009; 9: 677-682
38. Honczarenko M, Le Y, Swierkowski M et al. Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells 2006; 24: 1030-1041 (Pubitemid 44464736)
39. Ponte AL, Marais E, Gallay N et al. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 2007; 25: 1737-1745 (Pubitemid 47121852)
40. Togel F, Isaac J, Hu Z et al. Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury. Kidney Int 2005; 67: 1772-1784 (Pubitemid 40577712)
41. Xinaris C, Morigi M, Imberti B et al. A novel strategy to enhance mesenchymal stem cell migration capacity and promote tissue repair in an injury specific fashion. Cell Transplant; [Epub ahead of print]
42. Herrera MB, Bussolati B, Bruno S et al. Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney Int 2007; 72: 430-441 (Pubitemid 47237610)
43. Shi H, Patschan D, Dietz GP et al. Glial cell line-derived neurotrophic growth factor increases motility and survival of cultured mesenchymal stem cells and ameliorates acute kidney injury. Am J Physiol Renal Physiol 2008; 294: F229-F235
44. Mias C, Trouche E, Seguelas MH et al. Ex vivo pretreatment with melatonin improves survival, proangiogenic/mitogenic activity, and efficiency of mesenchymal stem cells injected into ischemic kidney. Stem Cells 2008; 26: 1749-1757
45. Hung SC, Pochampally RR, Hsu SC et al. Short-term exposure of multipotent stromal cells to low oxygen increases their expression of CX3CR1 and CXCR4 and their engraftment in vivo. PLoS One 2007; 2: e416
46. Cheng Z, Ou L, Zhou X et al. Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance. Mol Ther 2008; 16: 571-579 (Pubitemid 351314998)
47. Kumar S, Ponnazhagan S. Bone homing of mesenchymal stem cells by ectopic alpha 4 integrin expression. FASEB J 2007; 21: 3917-3927 (Pubitemid 350232349)
48. Hagiwara M, Shen B, Chao L et al. Kallikrein-modified mesenchymal stem cell implantation provides enhanced protection against acute ischemic kidney injury by inhibiting apoptosis and inflammation. Hum Gene Ther 2008; 19: 807-819
49. Yuan L, Wu MJ, Sun HY et al. VEGF-modified human embryonic mesenchymal stem cell implantation enhances protection against cisplatin-induced acute kidney injury. Am J Physiol Renal Physiol 2011; 300: F207-F218
50. Chen Y, Qian H, Zhu W et al. Hepatocyte growth factor modification promotes the amelioration effects of human umbilical cord mesenchymal stem cells on rat acute kidney injury. Stem Cells Dev 2011; 20: 103-113
51. Gooch A, Doty J, Flores J et al. Initial report on a phase I clinical trial: prevention and treatment of post-operative acute kidney injury with allogeneic mesenchymal stem cell in patients who require on-pump cardiac surgery. Cell Ther Transplant 2008; 1: 31-35
52. Togel FE, Westenfelder C. Mesenchymal stem cells: a new therapeutic tool for AKI. Nat Rev Nephrol 2010; 6: 179-183
53. Gaspari F, Cravedi P, Mandala M et al. Predicting cisplatininduced acute kidney injury by urinary neutrophil gelatinaseassociated lipocalin excretion: a pilot prospective case-control study. Nephron Clin Pract 2010; 115: c154-c160